Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 27, 2008The FASEB JournalOpen Access

Engagement of Toll‐like receptor‐2 on cytotoxic T‐lymphocytes occurs in vivo and augments antitumor activity

View Full Paper
Ask AI
Bookmark
Share

Authors

NANicole AsproditesLZLiqin ZhengFujian Normal UniversityDGDegui GengUniversity of Maryland, Baltimore

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Asprodites et al. (2008) studied this question.

synapsesocial.com/papers/6a754e138d2049c8dd036a79https://doi.org/10.1096/fj.08-108274
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1TLR9 engagement on CD4 T lymphocytes represses γ-radiation–induced apoptosis through activation of checkpoint kinase response elements2007 · 44 citations
  2. 2Cell-Based Immunotherapy with Suppressor CD8+ T Cells in Rheumatoid Arthritis2005 · 78 citations
  3. 3Human Effector CD8+ T Lymphocytes Express TLR3 as a Functional Coreceptor2006 · 124 citations
  4. 4Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling2007 · 592 citations
  5. 5The TLR-7 Agonist, Imiquimod, Enhances Dendritic Cell Survival and Promotes Tumor Antigen-Specific T Cell Priming: Relation to Central Nervous System Antitumor Immunity2006 · 207 citations